Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'APOLIPOPROTEIN C' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 201 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Katsuren, K; Tamura, T; Arashiro, R; Takata, K; Matsuura, T; Niikawa, N; Ohta, T
      Structure of the human acyl-CoA : cholesterol acyltransferase-2 (ACAT-2) gene and its relation to dyslipidemia

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
    2. Tomiyasu, K; Walsh, BW; Ikewaki, K; Judge, H; Sacks, FM
      Differential metabolism of human VLDL according to content of ApoE and ApoC-III

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    3. Bard, JM; Charles, MA; Juhan-Vague, I; Vague, P; Andre, P; Safar, R; Fruchart, JC; Eschwege, E
      Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity - The Biguanides and the Prevention of the Risk of Obesity (BIGPRO) 1 study

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    4. Yamamoto, M; Nakagawa-Ueta, H; Katoh, N; Oikawa, S
      Decreased concentration of serum apolipoprotein C-III in cows with fatty liver, ketosis, left displacement of the abomasum, milk fever and retained placenta

      JOURNAL OF VETERINARY MEDICAL SCIENCE
    5. Katoh, N
      In addition to the high-density lipoprotein fraction, apolipoprotein C-IIIis detected in chylomicrons and the very low-density lipoprotein fraction from serum of normolipidemic cows

      JOURNAL OF VETERINARY MEDICAL SCIENCE
    6. Kersten, S; Mandard, S; Escher, P; Gonzalez, FJ; Tafuri, S; Desvergne, B; Wahli, W
      The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism

      FASEB JOURNAL
    7. Dallongeville, J; Meirhaeghe, A; Cottel, D; Fruchart, JC; Amouyel, P; Helbecque, N
      Polymorphisms in the insulin response element of APOC-III gene promoter influence the correlation between insulin and triglycerides or triglyceride-rich lipoproteins in humans

      INTERNATIONAL JOURNAL OF OBESITY
    8. Shearer, GC; Couser, WG; Kaysen, GA
      Endothelial chylomicron binding is altered by interaction with high-density lipoprotein in Heymann's nephritis

      AMERICAN JOURNAL OF KIDNEY DISEASES
    9. Minnich, A; Tian, N; Byan, L; Bilder, G
      A potent PPAR alpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    10. Bremer, J
      The biochemistry of hypo- and hyperlipidemic fatty acid derivatives: metabolism and metabolic effects

      PROGRESS IN LIPID RESEARCH
    11. Talmud, PJ; Berglund, L; Hawe, EM; Waterworth, DM; Isasi, CR; Deckelbaum, RE; Starc, T; Ginsberg, HN; Humphries, SE; Shea, S
      Age-related effects of genetic variation on lipid levels: The Columbia University BioMarkers Study

      PEDIATRICS
    12. Oliver, WR; Shenk, JL; Snaith, MR; Russell, CS; Plunket, KD; Bodkin, NL; Lewis, MC; Winegar, DA; Sznaidman, ML; Lambert, MH; Xu, HE; Sternbach, DD; Kliewer, SA; Hansen, BC; Willson, TM
      A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    13. Dana, SL; Hoener, PA; Bilakovics, JM; Crombie, DL; Ogilvie, KM; Kauffman, RF; Mukherjee, R; Paterniti, JR
      Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat

      METABOLISM-CLINICAL AND EXPERIMENTAL
    14. Campos, H; Perlov, D; Khoo, C; Sacks, FM
      Distinct patterns of lipoproteins with apoB defined by presence of apoE orapoC-III in hypercholesterolemia and hypertriglyceridemia

      JOURNAL OF LIPID RESEARCH
    15. Dahim, M; Momsen, WE; Momsen, MM; Brockman, HL
      Specificity of the lipid-binding domain of apoC-II for the substrates and products of lipolysis

      JOURNAL OF LIPID RESEARCH
    16. Groenendijk, M; Cantor, RM; De Bruin, TWA; Dallinga-Thie, GM
      New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia

      JOURNAL OF LIPID RESEARCH
    17. Winegar, DA; Brown, PJ; Wilkison, WO; Lewis, MC; Ott, RJ; Tong, WQ; Brown, HR; Lehmann, JM; Kliewer, SA; Plunket, KD; Way, JM; Bodkin, NL; Hansen, BC
      Effects of fenofibrate on lipid parameters in obese rhesus monkeys

      JOURNAL OF LIPID RESEARCH
    18. Hsu, HC; Lee, YT; Yeh, HT; Chen, MF
      Effect of gemfibrozil on the composition and oxidation properties of very-low-density lipoprotein and high-density lipoprotein in patients with hypertriglyceridemia

      JOURNAL OF LABORATORY AND CLINICAL MEDICINE
    19. Schmidt, HHJ; Genschel, J; Baier, P; Schmidt, M; Ockenga, J; Tietge, UJF; Propsting, M; Buttner, C; Manns, MP; Lochs, H; Brabant, G
      Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    20. Groenendijk, M; De Bruin, TWA; Dallinga-Thie, GM
      Two polymorphisms in the apo A-IV gene and familial combined hyperlipidemia

      ATHEROSCLEROSIS
    21. Russo, GT; Meigs, JB; Cupples, LA; Demissie, S; Otvos, JD; Wilson, PWF; Lahoz, C; Cucinotta, D; Couture, P; Mallory, T; Schaefer, EJ; Ordovas, JM
      Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study

      ATHEROSCLEROSIS
    22. Starck, M; Schiele, F; Herbeth, B; Vincent-Viry, M; Beaud, B; Siest, G; Visvikis, S
      Apolipoproteins E and C-III in apo B- and non-apo B-containing lipoproteins in middle-aged women from the Stanislas cohort: effect of oral contraceptive use and common apolipoprotein E polymorphism

      ATHEROSCLEROSIS
    23. Etemad, B; Whitcomb, DC
      Chronic pancreatitis: Diagnosis, classification, and new genetic developments

      GASTROENTEROLOGY
    24. Groenendijk, M; Cantor, RM; Funke, H; Dallinga-Thie, GM
      Two newly identified SNPs in the APO AI-CIII intergenic region are strongly associated with familial combined hyperlipidaemia

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    25. Hubacek, JA; Waterworth, DM; Poledne, R; Pitha, J; Skodova, Z; Humphries, SE; Talmud, PJ
      Genetic determination of plasma lipids and insulin in the Czech population

      CLINICAL BIOCHEMISTRY
    26. Zhu, YJ; Bujo, H; Takahashi, K; Taira, K; Kobayashi, J; Koshikawa, H; Sasaki, Y; Kanoh, T; Saito, Y
      Severe hypertriglyceridemia with plasma inhibitory factor(s) on lipoprotein lipase activity in a patient with a common Ser(447)-Ter LPL mutation

      CLINICA CHIMICA ACTA
    27. Hertz, R; Sheena, V; Kalderon, B; Berman, I; Bar-Tana, J
      Suppression of hepatocyte nuclear factor-4 alpha by acyl-CoA thioesters ofhypolipidemic peroxisome proliferators

      BIOCHEMICAL PHARMACOLOGY
    28. Hegele, RA
      Monogenic dyslipidemias: Window on determinants of plasma lipoprotein metabolism

      AMERICAN JOURNAL OF HUMAN GENETICS
    29. Choudhury, AI; Chahal, S; Bell, AR; Tomlinson, SR; Roberts, RA; Salter, AM; Bell, DR
      Species differences in peroxisome proliferation; mechanisms and relevance

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    30. Choi, GR; Suh, SP; Song, JW; Kee, SJ; Shin, JH; Ryang, DW
      Genetic variation of the Apo Al-CIII-AIV gene cluster in hypertriglyceridemic patients with chronic renal failure undergoing hemodialysis

      JOURNAL OF KOREAN MEDICAL SCIENCE
    31. McCarron, MO; Nicoll, JAR; Stewart, J; Cole, GM; Yang, FS; Ironside, JW; Mann, DMA; Love, S; Graham, DI
      Amyloid beta-protein length and cerebral amyloid angiopathy-related haemorrhage

      NEUROREPORT
    32. Yamamoto, M; Katoh, N
      Decreased apolipoprotein C-III concentration in the high-density lipoprotein fraction from calves inoculated with Pasteurella haemolytica and bovine herpes virus-1

      JOURNAL OF VETERINARY MEDICAL SCIENCE
    33. Fang, D; Liu, B
      Apolipoprotein C-III can specifically bind to hepatic plasma membranes

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    34. Tornero, F; Garcia-Garzon, A; Rincon, B; Prieto, S; Uson, J; Lozano, L
      Apolipoproteins C-II and C-III abnormalities in hyperlipidemic and normolipidemic patients with chronic renal failure

      NEFROLOGIA
    35. Kalderon, B; Mayorek, N; Berry, E; Zevit, N; Bar-Tana, J
      Fatty acid cycling in the fasting rat

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    36. Willson, TM; Brown, PJ; Sternbach, DD; Henke, BR
      The PPARs: From orphan receptors to drug discovery

      JOURNAL OF MEDICINAL CHEMISTRY
    37. Batal, R; Tremblay, M; Barrett, PHR; Jacques, H; Fredenrich, A; Mamer, O; Davignon, J; Cohn, JS
      Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects

      JOURNAL OF LIPID RESEARCH
    38. Holzl, B; Kraft, HG; Wiebusch, H; Sandhofer, A; Patsch, J; Sandhofer, F; Paulweber, B
      Two novel mutations in the lipoprotein lipase gene in a family with markedhypertriglyceridemia in heterozygous carriers: potential interaction with the polymorphic marker D1S104 on chromosome 1q21-q23

      JOURNAL OF LIPID RESEARCH
    39. Grundy, SM
      Cholesterol-lowering therapy in secondary prevention: Remaining issues

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    40. Havel, RJ; Frost, PH
      The role of non-high-density lipoprotein-cholesterol in evaluation and treatment of lipid disorders

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    41. Kardassis, D; Pardali, K; Zannis, VI
      SMAD proteins transactivate the human apoCIII promoter by interacting physically and functionally with hepatocyte nuclear factor 4

      JOURNAL OF BIOLOGICAL CHEMISTRY
    42. de Man, FHAF; de Beer, F; van der Laarse, A; Jansen, H; Leuven, JAG; Souverijn, JHM; Vroom, TFFP; Schoormans, SCM; Fruchart, JC; Havekes, LM; Smelt, AHM
      The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia ismediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding

      ATHEROSCLEROSIS
    43. Dallongeville, J; Meirhaeghe, A; Cottel, D; Fruchart, JC; Amouyel, P; Helbecque, N
      Gender related association between genetic variations of APOC-III gene andlipid and lipoprotein variables in northern France

      ATHEROSCLEROSIS
    44. Attia, N; Durlach, V; Cambilleau, M; Roche, D; Girard-Globa, A
      Postprandial concentrations and distribution of apo C-III in type 2 diabetic patients. Effect of bezafibrate treatment

      ATHEROSCLEROSIS
    45. Sedova, L; Kazdova, L; Seda, O; Krenova, D; Kren, V
      Rat inbred PD/Cub strain as a model of dyslipidemia and insulin resistance

      FOLIA BIOLOGICA
    46. Marcais, C; Bernard, S; Merlin, M; Ulhmann, M; Mestre, B; Rochet-Mingret, L; Revol, A; Berthezene, F; Moulin, P
      Severe hypertriglyceridaemia in Type II diabetes: involvement of apoC-III Sst-I polymorphism, LPL mutations and apo E3 deficiency

      DIABETOLOGIA
    47. Lambert, DA; Smith, LC; Pownall, H; Sparrow, JT; Nicolas, JP; Gotto, AM
      Hydrolysis of phospholipids by purified milk lipoprotein lipase - Effect of apoprotein CII, CIII, A and E, and synthetic fragments

      CLINICA CHIMICA ACTA
    48. Ye, SQ; Kwiterovich, PO
      Influence of genetic polymorphisms on responsiveness to dietary fat and cholesterol

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    49. Galton, DJ; Ferns, GAA
      Genetic markers to predict polygenic disease: a new problem for social genetics

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    50. Zouali, H; Faure-Delanef, L; Lucotte, G
      Chromosome 19 locus apolipoprotein C-II association with multiple sclerosis

      MULTIPLE SCLEROSIS
    51. Jong, MC; Hofker, MH; Havekes, LM
      Role of ApoCs in lipoprotein metabolism - Functional differences between ApoC1, ApoC2, and ApoC3

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    52. Jansen, H; Chu, G; Ehnholm, C; Dallongeville, J; Nicaud, V; Talmud, PJ
      The T allele of the hepatic lipase promoter variant C-480T is associated with increased easting lipids and HDL and increased preprandial and postprandial LpCIII : B - European Atherosclerosis Research Study (EARS) II

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    53. Aouizerat, BE; Allayee, H; Cantor, RM; Dallinga-Thie, GM; Lanning, CD; de Bruin, TWA; Lusis, AJ; Rotter, JI
      Linkage of a candidate gene locus to familial combined hyperlipidemia - Lecithin : cholesterol acyltransferase on 16q

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    54. Bailey, CJ
      New pharmacological approaches to glycemic control

      DIABETES REVIEWS
    55. Watts, GF; Dimmitt, SB
      Fibrates, dyslipoproteinaemia and cardiovascular disease

      CURRENT OPINION IN LIPIDOLOGY
    56. Fruchart, JC; Duriez, P; Staels, B
      Peroxisome proliferator-activated receptor-alpha activators regulate genesgoverning lipoprotein metabolism, vascular inflammation and atherosclerosis

      CURRENT OPINION IN LIPIDOLOGY
    57. Gervois, P; Torra, IP; Chinetti, G; Grotzinger, T; Dubois, G; Fruchart, JC; Fruchart-Najib, J; Leitersdorf, E; Staels, B
      A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity

      MOLECULAR ENDOCRINOLOGY
    58. Gervois, P; Chopin-Delannoy, S; Fadel, A; Dubois, G; Kosykh, V; Fruchart, JC; Najib, J; Laudet, V; Staels, B
      Fibrates increase human REV-ERB alpha expression in liver via a novel peroxisome proliferator-activated receptor response element

      MOLECULAR ENDOCRINOLOGY
    59. Mukherjee, M; Kakkar, VV
      Enhancement of lipoprotein lipase activity by tissue factor pathway inhibitor

      THROMBOSIS AND HAEMOSTASIS
    60. Jong, MC; Van Dijk, KW; Dahlmans, VEH; Van der Boom, H; Kobayashi, K; Oka, K; Siest, G; Chan, L; Hofker, MH; Havekes, LM
      Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor

      BIOCHEMICAL JOURNAL
    61. Hussain, SS; Buraiki, J; Dzimiri, N; Butt, AI; Vencer, L; Basco, MC; Khan, B
      Polymorphism in apoprotein-CIII gene and coronary heart disease

      ANNALS OF SAUDI MEDICINE
    62. Edvardsson, U; Alexandersson, M; von Lowenhielm, HB; Nystrom, AC; Ljung, B; Nilsson, F; Dahllof, B
      A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643

      ELECTROPHORESIS
    63. Boyle, KE; Phillips, MC; Lund-Katz, S
      Kinetics and mechanism of exchange of apolipoprotein C-III molecules from very low density lipoprotein particles

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    64. Hodis, HN; Mack, WJ; Krauss, RM; Alaupovic, P
      Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: Clinical aspects

      CLINICAL CARDIOLOGY
    65. Tashiro, J; Kobayashi, J; Shirai, K; Morisaki, N; Saito, Y
      Modification of lipoprotein lipase catalytic activity by sialic acids

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    66. Asset, G; Staels, B; Wolff, RL; Bauge, E; Madj, Z; Fruchart, JC; Dallongeville, J
      Effects of Pinus pinaster and Pinus koraiensis seed oil supplementation onlipoprotein metabolism in the rat

      LIPIDS
    67. Sato, K; Takahashi, T; Takahashi, Y; Shiono, H; Katoh, N; Akiba, Y
      Preparation of chylomicrons and VLDL with monoacid-rich triacylglycerol and characterization of kinetic parameters in lipoprotein lipase-mediated hydrolysis in chickens

      JOURNAL OF NUTRITION
    68. Brown, PJ; Winegar, DA; Plunket, KD; Moore, LB; Lewis, MC; Wilson, JG; Sundseth, SS; Koble, CS; Wu, ZD; Chapman, JM; Lehmann, JM; Kliewer, SA; Willson, TM
      A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPAR alpha agonist with potent lipid-lowering activity

      JOURNAL OF MEDICINAL CHEMISTRY
    69. Xiang, SQ; Cianflone, K; Kalant, D; Sniderman, AD
      Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase

      JOURNAL OF LIPID RESEARCH
    70. Edvardsson, U; Bergstrom, M; Alexandersson, M; Bamberg, K; Ljung, B; Dahllof, B
      Rosiglitazone (BRL49653), a PPAR gamma-selective agonist, causes peroxisome proliferator-like liver effects in obese mice

      JOURNAL OF LIPID RESEARCH
    71. Marcoux, C; Tremblay, M; Nakajima, K; Davignon, J; Cohn, JS
      Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients

      JOURNAL OF LIPID RESEARCH
    72. Ribalta, J; Girona, J; Vallve, JC; La Ville, AE; Heras, M; Masana, L
      Vitamin A is linked to the expression of the AI-CIII-AIV gene cluster in familial combined hyperlipidemia

      JOURNAL OF LIPID RESEARCH
    73. Mekki, N; Christofilis, MA; Charbonnier, M; Atlan-Gepner, C; Defoort, C; Juhel, C; Borel, P; Portugal, H; Pauli, AM; Vialettes, B; Lairon, D
      Influence of obesity and body fat distribution on postprandial lipemia andtriglyceride-rich lipoproteins in adult women

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    74. Reddy, S; Yang, WB; Taylor, DG; Shen, XQ; Oxender, D; Kust, G; Leff, T
      Mitogen-activated protein kinase regulates transcription of the ApoCIII gene - Involvement of the orphan nuclear receptor HNF4

      JOURNAL OF BIOLOGICAL CHEMISTRY
    75. Tsujita, T; Sumiyoshi, M; Okuda, H
      Fatty acid alcohol ester-synthesizing activity of lipoprotein lipase

      JOURNAL OF BIOCHEMISTRY
    76. Kee, F; Amouyel, P; Fumeron, F; Arveiler, D; Cambou, JP; Evans, A; Cambien, F; Fruchart, JC; Ducimetiere, P; Dallongeville, J
      Lack of association between genetic variations of apo A-I-C-III-A-IV gene cluster and myocardial infarction in a sample of European male: ECTIM study

      ATHEROSCLEROSIS
    77. Auwerx, J
      PPAR gamma, the ultimate thrifty gene

      DIABETOLOGIA
    78. Waterworth, DM; Ribalta, J; Nicaud, V; Dallongeville, J; Humphries, SE; Talmud, P
      ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests

      CIRCULATION
    79. Brewer, HB
      Hypertriglyceridemia: Changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease

      AMERICAN JOURNAL OF CARDIOLOGY
    80. PANG CP
      MOLECULAR DIAGNOSTICS FOR CARDIOVASCULAR-DISEASE

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    81. SATO K; SUZUKI K; AKIBA Y
      SPECIES-DIFFERENCES IN SUBSTRATE-SPECIFICITY OF LIPOPROTEIN-LIPASE PURIFIED FROM CHICKENS AND RATS

      Comparative biochemistry and physiology. Part A, Molecular & integrative physiology
    82. HEGELE RA; BRECKENRIDGE WC; COX DW; MAGUIRE GF; LITTLE JA; CONNELLY PW
      ELEVATED LDL TRIGLYCERIDE CONCENTRATIONS IN SUBJECTS HETEROZYGOUS FORTHE HEPATIC LIPASE S267F VARIANT

      Arteriosclerosis, thrombosis, and vascular biology
    83. HUANG W; SASAKI J; MATSUNAGA A; NANIMATSU H; MORIYAMA K; HAN H; KUGI M; KOGA T; YAMAGUCHI K; ARAKAWA K
      NOVEL HOMOZYGOUS MISSENSE MUTATION IN THE APO A-I GENE WITH APO A-I DEFICIENCY

      Arteriosclerosis, thrombosis, and vascular biology
    84. MUKHERJEE R; STRASSER J; JOW L; HOENER P; PATERNITI JR; HEYMAN RA
      RXR AGONISTS ACTIVATE PPAR-ALPHA-INDUCIBLE GENES, LOWER TRIGLYCERIDES, AND RAISE HDL LEVELS IN-VIVO

      Arteriosclerosis, thrombosis, and vascular biology
    85. Burnett, JR; Barrett, PHR; Vicini, P; Miller, DB; Telford, DE; Kleinstiver, SJ; Huff, MW
      The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    86. SANTAMARINAFOJO S
      THE FAMILIAL CHYLOMICRONEMIA SYNDROME

      Endocrinology and metabolism clinics of North America
    87. Hertz, R; Bar-Tana, J
      Peroxisome proliferator-activated receptor (PPAR) alpha activation and itsconsequences in humans

      TOXICOLOGY LETTERS
    88. Hocquette, JF; Graulet, B; Olivecrona, T
      Lipoprotein lipase activity and mRNA levels in bovine tissues

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY
    89. PACKARD CJ
      OVERVIEW OF FENOFIBRATE

      European heart journal
    90. ARIMOTO I; MATSUMOTO C; TANAKA M; OKUHIRA K; SAITO H; HANDA T
      SURFACE-COMPOSITION REGULATES CLEARANCE FROM PLASMA AND TRIOLEIN LIPOLYSIS OF LIPID EMULSIONS

      Lipids
    91. MERO N; VANTOL A; SCHEEK LM; VANGENT T; LABEUR C; ROSSENEU M; TASKINEN MR
      DECREASED POSTPRANDIAL HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-E IN NORMOLIPIDEMIC SMOKING MEN - RELATIONS WITH LIPID TRANSFER PROTEINS AND LCAT ACTIVITIES

      Journal of lipid research
    92. BJORKEGREN J; KARPE F; VITOLS S; TORNVALL P; HAMSTEN A
      TRANSIENT TRIGLYCERIDEMIA IN HEALTHY NORMOLIPIDEMIC MEN INCREASES CELLULAR PROCESSING OF LARGE VERY-LOW-DENSITY LIPOPROTEINS BY FIBROBLASTSIN-VITRO

      Journal of lipid research
    93. BISGAIER CL; ESSENBURG AD; BARNETT BC; AUERBACH BJ; HAUBENWALLNER S; LEFF T; WHITE AD; CREGER P; PAPE ME; REA TJ; NEWTON RS
      A NOVEL COMPOUND THAT ELEVATES HIGH-DENSITY-LIPOPROTEIN AND ACTIVATESTHE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR

      Journal of lipid research
    94. ARIMOTO I; SAITO H; KAWASHIMA Y; MIYAJIMA K; HANDA T
      EFFECTS OF SPHINGOMYELIN AND CHOLESTEROL ON LIPOPROTEIN LIPASE-MEDIATED LIPOLYSIS IN LIPID EMULSIONS

      Journal of lipid research
    95. JONG MC; GIJBELS MJJ; DAHLMANS VEH; VANGORP PJJ; KOOPMAN SJ; PONEC M; HOFKER MH; HAVEKES LM
      HYPERLIPIDEMIA AND CUTANEOUS ABNORMALITIES IN TRANSGENIC MICE OVEREXPRESSING HUMAN APOLIPOPROTEIN C1

      The Journal of clinical investigation
    96. AVIRAM M; ROSENBLAT M; BISGAIER CL; NEWTON RS
      ATORVASTATIN AND GEMFIBROZIL METABOLITES, BUT NOT THE PARENT DRUGS, ARE POTENT ANTIOXIDANTS AGAINST LIPOPROTEIN OXIDATION

      Atherosclerosis (Amsterdam)
    97. MARTIN G; SCHOONJANS K; STAELS B; AUWERX J
      PPAR-GAMMA ACTIVATORS IMPROVE GLUCOSE-HOMEOSTASIS BY STIMULATING FATTY-ACID UPTAKE IN THE ADIPOCYTES

      Atherosclerosis (Amsterdam)
    98. BRITES FD; BONAVITA CD; CLOES M; YAEL MJ; FRUCHART JC; CASTRO GR; WIKINSKI RW
      VLDL COMPOSITIONAL CHANGES AND PLASMA-LEVELS OF TRIGLYCERIDES AND HIGH-DENSITY-LIPOPROTEIN

      Clinica chimica acta
    99. STAELS B; DALLONGEVILLE J; AUWERX J; SCHOONJANS K; LEITERSDORF E; FRUCHART JG
      MECHANISM OF ACTION OF FIBRATES ON LIPID AND LIPOPROTEIN METABOLISM

      Circulation
    100. HADZOPOULOUCLADARAS M; LAVRENTIADOU SN; ZANNIS VI; KARDASSIS D
      TRANSACTIVATION OF THE APOCIII PROMOTER BY ATF-2 AND REPRESSION BY MEMBERS OF THE JUN FAMILY

      Biochemistry (Easton)


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/10/20 alle ore 02:04:58